Accession | ARO:3007145 |
Definition | An antibiotic-adjuvant admixture of the beta-lactam antibiotic imipenem, beta-lactam potentiator cilastatin, and beta-lactamase inhibitor relebactam. |
SMILES | N/A |
Drug Class | carbapenem |
Classification | 10 ontology terms | Show + process or component of antibiotic biology or chemistry + resistance-modifying agents + inhibitor of antibiotic resistance mechanism + beta-lactamase inhibitor + antibiotic molecule + serine beta-lactamase inhibitor + beta-lactam antibiotic + host-related antibiotic adjuvants + diazabicyclooctane + carbapenem [Drug Class] |
Parent Term(s) | 4 ontology terms | Show + has_part imipenem [Antibiotic] + antibiotic mixture + has_part relebactam [Adjuvant] + has_part cilastatin [Adjuvant] |
Publications | Zhanel GG, et al. 2018. Drugs 78(1):65-98 Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. (PMID 29230684) Mansour H, et al. 2021. Am J Health Syst Pharm 78(8):674-683 Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination. (PMID 33580649) |
Curator | Description | Most Recent Edit |
---|